drugset / Trial / NCT01682564

To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure

NCT01682564

Phase 4 Completed 169 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare and evaluate the efficacy and safety of Candemore tab. versus Atacand tab. on blood pressure in patients with hypertension diagnosed congestive heart failure

Timeline

Start
2012-01
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan Unknown 4 mg
Subject Candesartan Unknown 8 mg
Subject Candesartan Unknown 16 mg
Comparator Candesartan cilexetil Unknown 4 mg
Comparator Candesartan cilexetil Unknown 8 mg
Comparator Candesartan cilexetil Unknown 16 mg